Found: 33
Select item for more details and to access through your institution.
Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 17, p. 1408, doi. 10.1093/jnci/80.17.1408
- By:
- Publication type:
- Article
Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions*.
- Published in:
- Clinical & Experimental Metastasis, 2000, v. 18, n. 4, p. 337, doi. 10.1023/A:1010833730407
- By:
- Publication type:
- Article
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
- Published in:
- 2003
- By:
- Publication type:
- journal article
γ-Radiation Sensitivity and Risk of Glioma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 20, p. 1553, doi. 10.1093/jnci/93.20.1553
- By:
- Publication type:
- Article
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
- Published in:
- Oncogene, 2002, v. 21, n. 15, p. 2357, doi. 10.1038/sj.onc.1205296
- By:
- Publication type:
- Article
Establishment of Prognostic Models for Astrocytic and Oligodendroglial Brain Tumors with Standardized Quantification of Marker Gene Expression and Clinical Variables.
- Published in:
- Biomarker Insights, 2010, n. 5, p. 153, doi. 10.4137/BMI.S6167
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_7, p. vii1, doi. 10.1093/neuonc/nou291
- By:
- Publication type:
- Article
Role of AKT signaling in DNA repair and clinical response to cancer therapy.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 10, p. 1313, doi. 10.1093/neuonc/nou058
- By:
- Publication type:
- Article
PRESENCE OF A DISTINCTIVE MYELOID POPULATION IS ASSOCIATED WITH THE INVASIVE TUMOR PHENOTYPE OBSERVED AFTER ANTI-ANGIOGENESIS THERAPIES.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii15, doi. 10.1093/neuonc/nou206.53
- By:
- Publication type:
- Article
DECIPHERING INTRINSIC AND ADAPTIVE RESISTANCE TO PI3K PATHWAY INHIBITORS IN GLIOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii37, doi. 10.1093/neuonc/nou208.56
- By:
- Publication type:
- Article
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 4, p. 567, doi. 10.1093/neuonc/not247
- By:
- Publication type:
- Article
Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 12, p. 1591, doi. 10.1093/neuonc/not219
- By:
- Publication type:
- Article
New Neuro-Oncology Practice Journal to Launch in 2014.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 10, p. 1277, doi. 10.1093/neuonc/not160
- By:
- Publication type:
- Article
Neuro-Oncology: Past Milestones and the Journey Ahead.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 11, p. 1453, doi. 10.1093/neuonc/not196
- By:
- Publication type:
- Article
Higher impact, wider influence.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 9, p. 1113, doi. 10.1093/neuonc/not135
- By:
- Publication type:
- Article
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 971, doi. 10.1093/neuonc/not106
- By:
- Publication type:
- Article
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 829, doi. 10.1093/neuonc/not024
- By:
- Publication type:
- Article
Year brings higher impact factor, more submissions for Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 1, p. 1, doi. 10.1093/neuonc/nos333
- By:
- Publication type:
- Article
Current clinical development of PI3K pathway inhibitors in glioblastoma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 7, p. 819, doi. 10.1093/neuonc/nos117
- By:
- Publication type:
- Article
The value of cell line validation.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 6, p. 675, doi. 10.1093/neuonc/nos132
- By:
- Publication type:
- Article
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 7, p. 748, doi. 10.1093/neuonc/nor037
- By:
- Publication type:
- Article
Pathway inhibition: emerging molecular targets for treating glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 6, p. 566, doi. 10.1093/neuonc/nor039
- By:
- Publication type:
- Article
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 6, p. 660, doi. 10.1093/neuonc/nor024
- By:
- Publication type:
- Article
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 509, doi. 10.1093/neuonc/nor017
- By:
- Publication type:
- Article
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 143, doi. 10.1093/neuonc/noq151
- By:
- Publication type:
- Article
Reflections on a Successful 2010.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 1, doi. 10.1093/neuonc/noq183
- By:
- Publication type:
- Article
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 10, p. 1061, doi. 10.1093/neuonc/noq072
- By:
- Publication type:
- Article
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1167, doi. 10.1093/neuonc/noq100
- By:
- Publication type:
- Article
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas†.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 1, p. 87
- By:
- Publication type:
- Article
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy†.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 1, p. 95
- By:
- Publication type:
- Article
Functional and molecular analyses of 10q deletions in human gliomas.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 24, n. 2, p. 135, doi. 10.1002/(SICI)1098-2264(199902)24:2<135::AID-GCC6>3.0.CO;2-A
- By:
- Publication type:
- Article
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anaplastic Oligodendrogliomas: Prognostic Factors for Tumor Recurrence and Survival.
- Published in:
- Oncology, 2003, v. 65, n. 3, p. 259, doi. 10.1159/000074479
- By:
- Publication type:
- Article